Drug Policy in China Transformations, Current Status and Future Prospects Xingzhu LiuShixue Li Leading Article 25 November 2012 Pages: 1 - 9
Publication Bias in Clinical Trials and Economic Analyses Nick FreemantleJames Mason Leading Article 25 November 2012 Pages: 10 - 16
Cost Effectiveness of the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism David R. AndersonBernie J. O’Brien Review Article 25 November 2012 Pages: 17 - 29
Economics of Thromboprophylaxis in Total Hip Replacement Surgery Jeff HarrisonDavid J. WarwickJoanna Coast Review Article 25 November 2012 Pages: 30 - 41
Cost-Effective Management of Diabetic Foot Ulcers Gunnel Ragnarson-TennvallJan Apelqvist Review Article 25 November 2012 Pages: 42 - 53
Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection Jeremy V. ChancellorAndrew M. HillMike Youle Original Research Article 25 November 2012 Pages: 54 - 66
Economic Evaluation of ACE Inhibitor Treatment of Nephropathy in Patients with Insulin-Dependent Diabetes Mellitus in Italy Livio GarattiniMassimo BrunettiMattia Barosi Original Research Article 25 November 2012 Pages: 67 - 75
Analysis of the Costs of NSAID-Associated Gastropathy Richard E. JohnsonMark C. HornbrookRobert Shneidman Original Research Article 25 November 2012 Pages: 76 - 88
Cost-Utility Analysis of Melphalan plus Prednisone With or Without Interferon-α2b in Newly Diagnosed Multiple Myeloma Erik NordFinn WisøffJan Westin Original Research Article 25 November 2012 Pages: 89 - 103